Abiopharma

Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

InMode Appoints Michael Dennison as President of North America

Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London

Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference

Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer

Halberd Corporation Continues Seeking Government Contracts with Scientists at Mississippi State University

Estrella Immunopharma Completes Second Dose Cohort in STARLIGHT-1 Trial of EB103 with Complete Responses in All Evaluable Patients

Ginkgo Bioworks Awarded Project Agreement through BARDAs BioMaP-Consortium

Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging